Arch Capital Group (NASDAQ:ACGL) Price Target Increased to $110.00 by Analysts at JPMorgan Chase & Co.
Arch Capital Group (NASDAQ:ACGL – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $110.00 in a research note...
Needham & Company LLC Reaffirms Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Needham & Company LLC reissued their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report issued on Thursday morning, Benzinga...
Applied Digital (NASDAQ:APLD) Price Target Raised to $11.00 at Lake Street Capital
Applied Digital (NASDAQ:APLD – Free Report) had its price target hoisted by Lake Street Capital from $7.00 to $11.00 in a research note issued to...
Atos SE (OTCMKTS:AEXAY) Sees Large Decline in Short Interest
Atos SE (OTCMKTS:AEXAY – Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was...
Sarepta Therapeutics (NASDAQ:SRPT) Receives Outperform Rating from Raymond James
Raymond James restated their outperform rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports....
BioMarin Pharmaceutical (NASDAQ:BMRN) Earns Outperform Rating from Raymond James
Raymond James reissued their outperform rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a report issued on Thursday morning, MarketBeat Ratings reports....